Protara Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 783 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 201-225 of 778 matching filings.

Per page
25
Current page
9
DEFA14A File 001-36694

DEFINITIVE ADDITIONAL MATERIALS

Filing date
26 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36694

ANNUAL REPORT

Filing date
26 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36694

PROXY STATEMENT

Filing date
26 Apr 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
10 Mar 2023
Reporting date
10 Mar 2023
Next action
Verify source filing
S-8 File 333-270354

REGISTRATION STATEMENT

Filing date
08 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36694

ANNUAL REPORT

Filing date
08 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
08 Mar 2023
Reporting date
08 Mar 2023
Next action
Verify source filing
SC 13G/A File 005-88372

AMENDMENT NO. 1

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
10 Feb 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Jan 2023
Reporting date
30 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2023
Reporting date
30 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
30 Jan 2023
Reporting date
30 Jan 2023
Next action
Verify source filing
4

4 filing

Filing date
20 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
05 Jan 2023
Reporting date
05 Jan 2023
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2022
Reporting date
30 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
03 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .